ADRB3 and metabolic dysfunction-associated steatotic liver disease: The above results indicate that activation of β3-AR can ameliorate gross morphological changes in the liver associated with NAFLD, improve liver function, regulate blood lipid and liver lipid levels, and protect against NAFLD.